Losartan prevents life-threatening insulin resistance in burn injuries

SAN FRANCISCO Researchers have found a way to prevent insulin resistance in burn-injured rats, a finding that, while still quite preliminary, could eventually save burn victims' lives and speed their recovery.

The researchers honed in on the renin-angiotensin system (RAS) as the key to preventing insulin resistance -- a unique line of inquiry in burn research, according to lead author Sherry O. Kasper. About 70% of serious burn victims develop insulin resistance, a condition marked by elevated levels of glucose and insulin.

Reversing the condition has the potential to reduce mortality, length of stay in intensive care and infection rates among severe burn patients, Kasper said. The American Physiological Society (APS) awarded Kasper a Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award in recognition of the exemplary research. Kasper also received the Mead Johnson Research Award in Endocrinology and Metabolism for the best abstract in endocrinology and metabolism by a graduate student, resident or postdoctoral fellow.

*Paper presentation: "Thermal injury induced insulin resistance is associated with the renin-angiotensin system (RAS)" 12:45 p.m.-3 p.m. Wednesday, April 5, Metabolism During Stress and Trauma 928.2/board #D407. On view 7:30 a.m. 3:30 p.m. Research was by Sherry O. Kasper, Scott M. Castle, Brian J. Daley, Blaine L. Enderson, Michael D. Karlstad, University of Tennessee Graduate School of Medicine, Knoxville, TN.

Drug blocks RAS

Insulin resistance occurs when the body senses glucose overload and attempts to reduce it by producing more insulin. When the additional insulin is unable to moderate the glucose, the body releases even more insulin. The result: elevated levels of both glucose and insulin. Burn-related insulin resistance can last for months, Kasper said.

Kasper became interested in RAS while studying the system as it relates to diabetes, blood pressure and aging. Karlstad,

Contact: Christine Guilfoy
American Physiological Society

Page: 1 2 3

Related biology news :

1. Critical protein prevents DNA damage from persisting through generations
2. Repair of DNA by Brca2 gene prevents medulloblastoma
3. Vaccine prevents prion disease in mice
4. New compound prevents alcoholic behavior, relapse in animals by blocking stress response
5. Cold Spring Harbor Laboratory scientists discover new gene that prevents multiple types of cancer
6. Antibody therapy prevents type 1 diabetes in mice
7. Cambridge led team discovers gene mutation which prevents carriers from feeling pain
8. The abortion pill compound prevents breast tumor growth
9. Vaccination with embryonic stem cells prevents lung cancer in mice
10. Turmeric prevents experimental rheumatoid arthritis, bone loss, University of Arizona study shows
11. Early treatment prevents lasting breathing problems in some premature babies

Post Your Comments:

(Date:10/17/2019)... ... 15, 2019 , ... Modality Solutions, a biopharmaceutical ... on the Houston Business Journal’s Fast 100 list. Modality Solutions ranked No. 91 ... in Houston, Modality Solutions is a biopharmaceutical cold chain engineering firm with regulatory ...
(Date:10/11/2019)... ... October 11, 2019 , ... ... surgeon, oncologist, and researcher Dr. Pavel Tyan has been appointed Therapeutic Lead for ... the organization, further enhancing the already strong scientific and delivery credentials previously offered ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... that make it easier than ever for businesses and organizations to use their ... App enables organizations to count down to or count up from date-related milestones, ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, the ... the midway point of its randomized research trial for individuals with persisting symptoms ... the efficacy of a non-invasive technology which compares tones delivered to a subject’s ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... is pleased to announce that it has moved into a new, 5000 sqft, ... instruments, the new facility demonstrates the company's continuous commitment to quality research and ...
(Date:9/24/2019)... Mass. (PRWEB) , ... September ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, a ... and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd ... Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney ...
Breaking Biology Technology:
Cached News: